I Introduction
Most instances of medical malpractice never become lawsuits. Either they go undetected, or the injured party chooses not to pursue the matter.
1 Most medical malpractice lawsuits never get to trial. 2 Nonetheless, decisions about the disposition of a medical malpractice case, and even the decision whether to file a case, are made against the backdrop of one question: what would happen at trial? In other words, trials matter. They matter, not so much for their own sake, but for the effect they have on other cases. 3 Medical malpractice has seldom suffered from a lack of academic attention. The topic seems to fascinate researchers across disciplines, including medicine. 4 Nonetheless, there are aspects of medical malpractice litigation that deserve closer attention. Trials, for example, are difficult to examine in detail. Verdict outcomes can be gathered easily enough, but collecting the information surrounding trials is more difficult. What do medical malpractice trials look like? What are their characteristics? Do caps on damages make a difference in outcome? These are the questions this paper explores.
This research was made possible by the willingness of one of the major insurers of physicians in North Carolina and Virginia to give us access to their closed files. No restrictions were imposed by the insurer. We were able to see the same information the insurer's adjusters were able to see. We had access to information regarding the nature and severity of the plaintiff's injuries, the medical specialty of the defendant physician, the identities of plaintiff's and defense counsel, the costs and results of the trials, the amounts of settlements during trial, and the location and dates of the trials. We also had access to the running notes maintained by the adjusters as the cases progressed. 5 What follows is a description and comparison of medical malpractice trials conducted in North Carolina and Virginia between the years 2000 and 2010.
We collected data on trials in Virginia and trials in North Carolina, consisting of all the closed cases that went to trial in those two states between 2000 and 2010 in which the insurer was involved. Because our data is limited to cases in which a particular insurer was involved, our dataset does not include all medical malpractice trials conducted in those two states. 6 However, we believe the results we report are representative.
II. Virginia
Virginia first imposed a cap on medical malpractice damages in 1977. 7 The original cap of $750,000 was increased to $1,000,000 in 1983 8 and to $1,500,000 in 1999.
9 Thereafter, the cap was increased by statute by $50,000 per year until 2008. 10 Since 2008, the cap has remained at $2,000,000. 11 Unlike most states with limits on medical malpractice damages, the Virginia cap is a "hard cap," meaning that all damages, both economic and non-economic, are subject to the statutory limits. 12 In 1989, the Virginia legislation was upheld against constitutional challenge by the Virginia Supreme Court. 13 In contrast, during the time period studied (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) , North Carolina did not impose limits on the amount of damages that may be awarded in a medical malpractice lawsuit.
14 The juxtaposition of these two states, in which the same insurance company writes medical malpractice insurance policies, provides an opportunity to examine the effect of damage caps in practice.
Other than the existence of the statutory cap on damages in Virginia, the common law of torts is generally the same in both states. 15 With regards to medical malpractice, there are two differences to note. First, as to the applicable standard of care, Virginia law contemplates a state-wide standard, while allowing for exceptions when the standard of local health care services and facilities would be "more appropriate" than a state-wide standard. 16 In North Carolina, the standard of care is to be determined by reference to the standards followed in the same or similar localities. 17 Second, Virginia by statute limits the number of experts who may be called to testify at trial to two per medical discipline. 18 North Carolina law imposes no restriction on the number of experts at trial.
We collected data on 90 trials conducted in Virginia. Some of these cases involved more than one insurer. Based on our review of the insurance files, we believe that in most of the cases, the insurer was the primary insurer. In 77 of the trials, the insurer was the only insurer. Of the 90 trials, the majority resulted in defense verdicts (n=51). One additional case ended in a directed verdict for the defendant.
19 A plaintiff's verdict was returned in twenty-five cases. Eleven cases were settled before verdict, and the remaining two trials ended in a hung jury. Relatively few of these cases were appealed. When they were appealed, it made no difference. All 12 of the cases that were appealed (six defense verdicts and six plaintiff's verdicts) were affirmed. The results are summarized in Table 1 . Comparing only verdicts, plaintiffs prevailed 32.5% of the time (25/77). If "settled before verdict" results are counted along with plaintiff verdicts, the success rate for plaintiffs improved to 40.1%. (36/88).
The 25 plaintiff's verdicts ranged greatly in amount, from a low of $42,000 to a high of $7,000,000 (before application of the cap), with a mean verdict amount of $1,276,935 and a median amount of $500,000. Five verdicts were for $100,000 or less; ten verdicts exceeded $1,000,000 (before application of the cap). Table 2 summarizes trial results by year in Virginia. 2001  2  2  ----2002  7  1  1  3  2  -2003  9  5  -2  2  -2004  14  9  -2  3  -2005  13  6  -4  1  2  2006  11  8  -3  --2007  10  8  -2  --2008  11  5  -5  1  -2009  9  6  -3  --2010  4  1  -1  2  -Total  90  51  1  25  11  2 By year, the numbers are small and no pattern emerges. In two years -2002 and 2008 -plaintiffs fared particularly well, winning either by trial or settlement prior to verdict more than half the time.
Of the twenty-five cases tried to a plaintiff's verdict, six were affected by the statutory cap. The verdicts ranged from $2,200,000 to $7,000,000; all but two were in the amount of $2,500,000 or less. The $7,000,000 verdict was the result of a lawsuit brought by a young, married attorney who alleged that his internist failed to diagnose subacute endocarditis, and that as a result, the plaintiff suffered a stroke, and congestive heart failure. The verdict was rendered in the second trial of the case; the first trial had resulted in a hung jury. The $6,500,000 verdict involved a middle aged, married white male; the medical allegation was failure to diagnose cancer. The severity of the injury to plaintiff was category eight, grave. Both plaintiffs in these two cases were represented by the same attorney.
As is typical in states with damage caps, the jury was not told of the existence of the cap. It was, instead, applied afterwards; in the six cases that exceeded the statutory cap, the cases were resolved at the applicable cap amount.
For example, the $7,000,000 verdict was rendered in 2009, when the cap was $2,000,000. The plaintiff thus took a $5,000,000 "haircut."
In the other nineteen cases, the cap was not reached. When all trials are considered, regardless of outcome, the direct effect of the damage cap seems even less -caps mattered in less than 7% (6/90) of the cases studied. The true impact of the cap, however, was felt in the cases that settled. Because the cap operated as a limit on the maximum amount of damages that could be awarded at trial, it also had the effect of limiting the maximum amount of damages that could be paid in settlement. For example, the effect of the caps can be seen in the data for the eleven cases that went to trial, but were settled before a verdict was rendered. The settlements ranged from $125,000 to $1,250,000, with a mean of $445,909 and a median of $400,000.
The length of the trials that went to verdict varied from 1 day to 9 days, with a median of three and one-half days (n=76). There was a noticeable decrease from the number of defendants (whether or not they were insured by the same insurer) originally sued, and the number of defendants at trial. For example, in 41 of the 90 trials we examined, more than one defendant was sued (45.6%). By the time of trial, less than 14% of trials (12/89) had more than one defendant.
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For the most part, serious injuries were at issue in the trials. This should not be a surprise. Medical malpractice trials are expensive. They are brought by attorneys whose compensation depends on obtaining money for their clients. Plaintiffs' counsel typically invest not only their time in preparing their cases; they usually finance the costs of developing the case themselves. Only if there is a recovery will those expenses be reimbursed. The point is simple: to take a medical malpractice case to trial, a substantial sum of money has to be sought. Because there is a rough correlation between severity of injury and the level of compensation, most medical malpractice trials involve quite serious injuries.
22
The insurer used a severity of injury scale similar to that used by the National Association of Insurance Commissioners (NAIC).
23 Table 3 summarizes the distribution of injuries, by severity. 21 In one case, we were unable to determine the number of defendants at trial. This finding is consistent with results from Texas reported by Black et al. See Bernard Black, Charles Silver, David Hyman and William Sage, Stability, Not Crisis: Medical Malpractice Claims in Texas, 1988 -2002 , 2 J. EMP. L. Studies 207, 228 (2005 . The authors suggest that plaintiffs' counsel frequently name multiple physicians as defendants, including some physicians whose involvement was insignificant. 22 Hyman and Silver, supra n. 1 at 1118 (suggesting that a malpractice claim, without regard to the merits, has to involve losses of at least $50,000 to be worth pursuing -and that observation was made five years ago). 23 The injury scale used was as follows: Usually it was the attending physician who was the sole or, if more than one physician was sued, the primary defendant (68/90, 75.6%). Consulting physicians accounted for most of the remaining cases (13/90, 14.4%). The overall success rate for plaintiffs was about the same for suits against attending physicians (24/66, 36.4%) as for suits against consulting physicians (5/13, 38.5%). Most of the lawsuits alleged injuries that occurred while the patient/plaintiff was in the hospital (56/90, 62.2%), followed by injuries allegedly sustained in the practitioner's office (25/90, 27.8%). Based on the results at trial, plaintiffs' chances were better if the injury took place in the practitioner's office (13/24, 54.2%) than in the hospital (18/55, 32.7 %).
Plaintiffs' ages varied considerably, from infancy (n=5) to 81 years of age. More than half (n= 53) of the plaintiffs were women, and most of the plaintiffs (n=54) were married. The chances of success at trial (either a plaintiff's verdict or a settlement before verdict) were higher for men (16/36, 44.4%) than for women (19/51, 37.3%). We lack complete information regarding other demographic measures. The tables below report demographic information for the plaintiffs for which this information is available. The number of plaintiffs studied is small, but based on our data most plaintiffs were white, married, and privately insured. There were more female plaintiffs than male plaintiffs. About half of the plaintiffs worked, either full-time, part-time or self-employed, and most plaintiffs had private medical insurance. A substantial portion of the plaintiffs (25/72, 34.7%) were either retired or disabled.
Plaintiff's allegations of injury covered most systems of the body, and a wide range of affected body parts. Injuries involving the musculo-skeletal system (n=22), the digestive system (n=17), the reproductive system (n=16) and the cardiovascular system (n=15) were most frequently alleged, accounting for more than 77% of the cases that went to trial. Twenty-two of the cases were labeled "surgery related," followed by "treatment related" (n=16) and "diagnosis related" (n=15). 24 The most common medical allegation (the basis for claiming negligence) was inappropriate or incomplete treatment (n=25), followed by failure to diagnose disease (n=9) and failure to monitor the patient's status while in treatment (n=7).
Plaintiffs' chances were best when the nature of the allegation was "diagnosis related." In ten of fourteen cases, 25 plaintiffs either obtained a verdict, or a settlement before verdict. Plaintiff's chances were worst when the nature of the allegation was "surgery related" (3/21, 14.3%).
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Plaintiff's lawyers who took medical malpractice cases to trial during the ten years studied (2001-2010) did not do so often. Of the 65 plaintiff's lawyers who tried at least one of these cases, most (n= 51) tried only one case. The highest number of trials by a plaintiff's lawyer was eight; one lawyer conducted five trials, and two lawyers conducted four trials. This relative lack of concentration may be due to a number of factors, but two of them stand out. First, there are no entry requirements to represent a plaintiff in a medical malpractice trial, other than being a member of the state bar. In contrast, defending a medical malpractice case requires a decision by the defendant physician's insurer. Second, for plaintiff's counsel, it requires either skilful case selection or considerable luck to expect to prevail at trial. It is likely, after all, that the insurer has identified and settled most of the cases it expects to lose, well before a jury is selected. 27 It is worth noting that of the four plaintiff's attorneys who tried four or more cases, only one had a winning record: winning two, losing two, and settling a fifth case before verdict. A second attorney won three, lost four, and settled one case before verdict. 24 For this particular category (nature of allegation), n=61. This category was added by the insurer after 2001. As a result, not all cases contain this information, For "system" and "medical allegation" however, n=90 (all cases). 25 The fifteenth case resulted in a hung jury. 26 An additional case resulted in a hung jury. 27 A different picture emerges on the defense side. A total of 18 attorneys conducted the 90 trials, but the use of defense attorneys was actually more concentrated than that: five attorneys accounted for over 67% (61/90) of the trials. The records of these five attorneys is almost the mirror image of the four plaintiff's attorneys with the most trials: three of them had winning records; the fourth won four, lost one, and settled three cases before verdict, while the fifth won seven, lost eight, and settled one case before verdict.
From the defense side, the cases were expensive to try. Recorded expenses for those defendants who went to trial ranged from a low of $16,360 to a high of $525,255, with a mean of $170,996 and a median of $147,147. Expressed in 2010 dollars, the average cost of defense rose from $148,913 in 2001 to $345,676 in 2010. Not all defendants named in a lawsuit go to trial, however. A defendant might be dismissed, for example, or a defendant might reach a separate settlement with the plaintiff. As a result, total expenses on a per case basis were somewhat higher, with a mean expense of $177,561 and a median expense of $151,174. Expressed in 2010 dollars, the average total expense on a per case basis rose from $148,913 in 2001 to $358,186 in 2010.
The venue of the trial appeared to matter, although the numbers are small. While defense verdicts around the state were more common than plaintiff's verdicts, plaintiffs did well in Alexandria, in northern Virginia (two plaintiff's verdicts and one case settled before verdict, against one defense verdict), and in Portsmouth (three plaintiff's verdicts and three settlements before verdict, against four defense verdicts). The defense did well in Virginia Beach, winning four verdicts, and losing only one, and in Fairfax County (also in northern Virginia), winning eleven verdicts, losing four, and settling three cases.
Based on a review of the insurer's files, we were able to determine the insurer's internal assessment of liability, prior to trial, in 52 of the 90 trials. 28 We developed a liability scale from 1 to 5, as follows:
1-No liability 2-Doubtful liability 3-Uncertain liability 4-Probable liability 5-Clear liability The insurer's trial prognostications were generally accurate. The defense prevailed in 23 of the 30 cases rated as either no or doubtful liability (76.7%). Of the 12 cases rated as uncertain liability, the defense won 8 and lost 6 (57.1%). The defense lost seven of eight cases rated as probable or clear liability; the eighth case ended in a hung jury.
III. North Carolina
We collected data on 167 trials in North Carolina. Based on a review of the data, we believe that the insurer was the primary insurer in more than 80% of the trials (142/167; 85%). Of the 167 trials, 124 ended in defense verdicts, 17 ended in plaintiff's verdicts, and 18 were settled before verdict. Of the remaining 8 trials, there were 3 directed verdicts for the defense; three hung juries, one JNOV following a defense verdict, and one JNOV following a plaintiff's verdict. As in Virginia, few cases were appealed. Of the twelve cases appealed, ten were affirmed (eight for the defense, two for the plaintiff). An additional appeal was dropped by the defense. There was only a single reversal -a JNOV granted for the plaintiff was reversed on appeal. Table 7 summarizes the results. By any measure, taking a plaintiff's medical malpractice case to trial in North Carolina was a long shot. Comparing only defense and plaintiff's verdicts, the defense won 88.2% of the time (127/144). Counting settlements before verdict along with plaintiff's verdicts, the defense still prevailed more than 78% of the time (127/162). These results are generally consistent with earlier studies of medical malpractice trials in North Carolina and elsewhere. 29 The 17 plaintiff's verdicts ranged in amount from $32,500 to $2,750,000 (mean $658,782 median $375,000. The 18 trials settled before verdict ranged in amount from $100,000 to $1,900,000 (mean $574,583, median $425,000).
When the results are analyzed by year, the story does not change. Comparing only cases tried to verdict, the defense success rate ranged from a low of 76.2% (2001) to a high of 100% (2007 and 2010) . When settlements before verdict are included as successes for the plaintiff, the results improve for plaintiffs, but still heavily favor the defense. Plaintiff's highest rate of success was 33.3%, in 2003. The trend over time suggests an increasing level of defense success at trial. Since 2005, plaintiffs averaged less than one verdict a year: one verdict in 2005, 2006, 2008, and 2009, and no verdicts in 2007 and 2010 . Over those six years, only one verdict exceeded $1,000,000, in 2006 for $1,500,000. From the plaintiff's perspective, to borrow a line from the Grateful Dead, the situation was even worse than it appeared. The length of the trials (n=113) that went to verdict varied from 1 day to 30 days, with a median of 8 days. 31 As observed in Virginia, there was a noticeable decrease from the number of defendants originally sued (without regard to the identity of their insurer) and the number of defendants at trial. More than one defendant was originally sued in almost half (n=79) of the North Carolina trials. By the time of trial, however, only 36 cases had more than one defendant. Of those 36 trials with multiple defendants, only 5 involved more than two defendants. 32 30 "Touch of Gray," Grateful Dead. 31 Virginia trials were generally shorter, with a median length of four days. The disparity in the median number of trial days may be due, at least in part, to Virginia's limit on the number of expert witnesses who may be called at trial. See n. 18 supra and the accompanying text. 32 One case had three defendants, two cases had four defendants, and one case had nine defendants.
The alleged injuries at issue in the trials were usually serious in nature. Table 9 summarizes the distribution of injuries by severity, again using a scale similar to that used by the NAIC 33 , with the outcome at trial. A review of the table indicates that plaintiff's chances at trial were never good, regardless of the severity of the injury. The "win" percentage (determined by counting plaintiff's verdicts, "settled before verdict," and JNOV-for plaintiff, and dividing that sum by the total of all trials (minus hung juries), exceeded 30% for only one category -grave permanent -and there were only two cases in that category. Plaintiff's chances for success were best for three of the more serious types of injury: significant permanent, grave permanent, and death (categories 6, 8 and 9). 34 In contrast, plaintiffs never recovered for the three types of injury deemed least severe: emotional injury, temporary insignificant, and temporary minor. More than half of the cases settled after a trial had begun, but before a verdict, were death cases. In fact, all but one of the cases settled before verdict involved permanent injuries, suggesting that settlement became more attractive when the stakes were high.
The same three practice specialties that dominated medical malpractice trials in Virginia also dominated medical malpractice trials in North Carolina, but not to the same extent. General Surgery (20), Orthopedic Surgery (20) and Ob-Gyn (17) accounted for more than one-third of the trials (57/167, 34.2%). Forty-eight of those trials resulted in a defense verdict, three in a plaintiff's verdict, and five settled before verdict. 35 The "win" percentages (counting both plaintiffs' verdicts and settlements before verdict as wins) were 20% against general surgeons (4/20), 18.8% against Ob-Gyns (3/16), and 5% against orthopedic surgeons. Surgical specialties overall accounted for slightly more than half (89/167) of the trials. The most frequent non-surgical specialty at trial was internal medicine (n=16), 36 followed by family practice (n=11).
The principal defendant was most often identified as the attending physician (n=115, 68.9%), followed by consulting physicians (n= 37, 22.1%). Physicians identified as covering or on-call accounted for almost all of the remaining cases. Plaintiffs' chances of success were best when the primary defendant was a consulting physician (30.6%). When an attending physician was sued, plaintiffs were less successful (18.9%).
Most of the trials (115/167, 68.9%) were based on injuries alleged to have occurred while the patient/plaintiff was in the hospital. The second most frequent location of the alleged injury was the practitioner's office (37/167, 22.2%). Hospital outpatient facilities, surgi-centers, emergi-centers, and ambulatory care accounted for the balance. The location of the alleged injury did not seem to have much effect on plaintiffs' chances of success, with one exception. When the injury allegedly occurred in a hospital outpatient facility, plaintiffs prevailed more than half the time: two plaintiffs' verdicts and three settlements before verdict, against four defense verdicts. This result is intriguing, but the relatively small number of cases involving a hospital outpatient facility makes any generalization dangerous.
Plaintiffs ranged in age from infancy (less than one year old) to 89. More than half (n=89) were female. Most of the plaintiffs were married. The percentage of success at trial (either a plaintiff's verdict or a settlement before verdict) was almost the same for women (21.6%) and for men (21.3%).We lack complete information regarding other demographic measures. The tables below report demographic information for the plaintiffs for which this information is available: The demographic patterns for plaintiffs are similar to those for Virginia. More plaintiffs were female rather than male. Most plaintiffs were married, white and employed, and most had private medical insurance. As in Virginia, a substantial minority of plaintiffs were either disabled or retired (27/120, 24.0%).
As in Virginia, plaintiff's allegations of injury covered most systems of the body, and a wide range of affected body parts. Injuries involving the musculoskeletal system (n=37), the digestive system (n=31), the cardiovascular system (n=29), and the reproductive system (n=23) were most frequently alleged, accounting for more than 72% of the cases that went to trial. There were twentythree "diagnosis related" cases, twenty-three "surgery related" cases, and twentyone "treatment related" cases" (n=85). Out of 166 cases, the most common medical allegation (the basis for claiming negligence) was inappropriate or incomplete treatment (n=22), followed by failure to monitor the patient's status while in treatment (n=20), failure to diagnose disease (n=13) and other diagnostic error (n=13).
Again as in Virginia, plaintiffs' chances of success were best when the nature of the allegation was "diagnosis related," but the end results were not nearly as favorable. Plaintiffs obtained a verdict, or settlement before verdict, in six of twenty-one cases (28.6%). Once again, plaintiffs' chances were worst when the nature of the allegation was either "surgery related" (3/23, 13%) or "treatment related (2/21, 9.5%).
One hundred and seven different plaintiff's attorneys accounted for the North Carolina trials. 37 Two attorneys tried five cases, three attorneys tried four cases, and nine attorneys tried three cases. The remaining 93 attorneys tried either one or two cases. Of the twelve attorneys who tried three or more cases, only two had a success rate above 50%, even when counting "settled before verdict" as a plaintiff "win."
In contrast, only twenty-six defense attorneys were retained by the insurer to conduct the trials. The level of concentration was actually even more pronounced on the defense side. Seven attorneys accounted for 106 of the trials (63.5%), and two attorneys accounted for 52 of the trials (31.1%). None of the twenty-six attorneys had a success rate below 50%. Looking only at cases tried to verdict, the seven defense attorneys with the highest number of trials won 79 times, and lost a total of 12 times -a percentage of 86.8%. When settlements before verdict are included, these seven defense counsel still prevailed over 75% of the time (79/104). 38 One inference from these results is that success at trial brings more cases, and more trials, from the insurer. A related inference is that the insurer, able to offer steady (if at a discounted rate) work, limits its choices to experienced, successful trial attorneys. The "repeat player" effect 39 should not be overlooked, either: familiarity breeds success. Still, in light of the poor success rate at trial for plaintiffs' counsel with three or more trials, the "repeat player" effect seems onesided. Something else must have been going on.
The cases were expensive to defend. Recorded expenses for those defendants who went to trial ranged from a low of $25,350 to a high of $891,957, 40 with a mean of $220,728 and a median of $173,031 -both substantially higher than comparable Virginia expenses. As in Virginia, total expenses on a per case basis were higher, with a mean expense of $230,937 and a median expense of $174,708. Expressed in 2010 dollars, the average expense incurred for cases that went to trial increased from $147,009 in 2001 to $331,333 in 2010. Although we did not analyze expense costs in terms of its components, it is likely that legal fees were the single largest contributor to overall costs of defense. 41 On average, expense costs were less in cases that ended in a defense verdict ($224,605 mean, $199,858 median) than in cases that ended in a plaintiff's verdict ($255,915 mean, $244,684 median). The highest average trial expense, however, was for cases that settled before verdict ($257,993 mean, $256,396 median).
Expressed in 2010 dollars, plaintiffs' verdicts and settlements before verdict were similar in average and median expense. Both results were more expensive (by more than $35,000) than defense verdicts, as Table 13 illustrates. Where the case was tried did not usually matter, regarding the result. In most counties, defense verdicts were the rule. However, in three counties with more than two trials, plaintiffs' success rate equaled or exceeded 50%: Rutherford (one defense verdict, two settled before verdict); Cumberland (Fayetteville) (five defense verdicts, three plaintiff verdicts, and two settled before verdict); and Pitt (Greenville) (two defense verdicts, one plaintiff's verdict, and one settled before verdict). 42 In contrast, in Buncombe County (Asheville), there were fifteen defense verdicts and two plaintiff's verdicts; in Wake County (Raleigh), there were fourteen defense verdicts, one settlement before verdict, and one hung jury; and in Mecklenburg (Charlotte), there were eleven defense verdicts, two plaintiff's verdicts, and two settlements before verdict.
In light of these lopsided results at trial, a simple question arises: why? Based on our research, we believe the answer is simple. The insurer was simply careful about choosing the cases that went to trial. Cases that the insurer expected to lose were usually settled. It follows, then, that the insurer expected to win the bulk of the cases that went to trial, based on its own internal assessments of liability. Research from other states indicates that claims not involving a medical error (as determined by physician reviewers after the fact) were twice as likely to go to trial as claims involving a medical error -and much less likely to result in compensation. 43 Although it takes the agreement of both parties to reach a settlement, it would be a naïve plaintiff's lawyer who was unaware of the pattern of verdicts at trial. In North Carolina at least, whenever the insurer made an offerany offer -the case almost always settled. Based on a review of the insurer's files, we were able to determine the insurer's internal assessment of liability, prior to trial, in 89 of the 167 trials. 45 We developed a liability scale from 1 to 5, as follows:
1-No liability 2-Doubtful liability 3-Uncertain liability 4-Probable liability 5-Clear liability
The insurer was more accurate in its predictions in North Carolina than in Virginia. Of the 58 cases rated by the insurer as either no or doubtful liability, the defense prevailed 54 times (93.1%). Two cases ended in hung juries, one settled before verdict, and one ended in a JNOV for the plaintiff, following a defense verdict. Of the 21cases rated by the insurer as uncertain liability, 14 (66.7%) resulted in defense verdicts; five in plaintiff's verdicts; and 2 settled before verdict. Of the remaining 10 cases (rated as either probable or clear liability), 3 ended in plaintiff's verdicts, and 7 were settled before verdict.
It is no accident that the bulk of the 89 cases (65%) were rated as cases of no or doubtful liability. What, then, explains the insurer's willingness to try the remaining thirty cases? Several factors were likely at play. First, the insurer's policies included a "consent to settle" clause, meaning that any settlement required the consent of the insured. A defendant unwilling to settle had the contractual right to force a trial. Second, the insurer may have been unable, at times, to reach an agreement with the plaintiff regarding a settlement amount -with the question being left to the jury. Even so, of the ten cases with probable or clear liability, a settlement was reached prior to verdict seven times. Finally, for cases of uncertain liability, the insurer (and the insured) may have been willing to take its chances with a jury. More often than not, in cases of uncertain liability, it was a risk worth taking. The defense won two-thirds of the cases rated as "uncertain liability." Eleven verdicts were for $1,000,000 or more. The highest verdict awarded was for $10,437,093 in 2007.
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The insurer's results are included in the above table. Thus, the insurer accounted for over 60% (135/217) of the medical malpractice trials in North Carolina tried to a verdict during the years 2001-2009. 49 For these nine years, the insurer's success rate at trial (87%) exceeded the overall defense success rate (78.8%).
IV. Discussion
Over the ten year period studied, six of the twenty-six plaintiff's verdicts in Virginia were affected by the cap on damages. Of those six, two verdicts, for $7,000,000 and for $6,500,000, were substantially in excess of the cap. Based on the data reported in Table 14 above, several North Carolina verdict would have run afoul of Virginia's cap as well. 50 However, the true effect of the cap is more subtle than a few verdict "haircuts." Its effect can be inferred from the cases settled before verdict, and from the cases that were settled prior to trial. In effect, the cap sets a ceiling on all malpractice settlements. This de facto ceiling on recovery has a second, related effect. When the amount that can be recovered is capped, so too is the attorney's contingency fee. Whether the fee percentage is one-fourth, one-third, or two-fifths, that fraction will be multiplied by a number that has a ceiling -the cap. For cases that require a substantial amount of pre-trial preparation, the costs of which will be borne initially by plaintiff's counsel, the prospect of a limited award may be enough to dissuade counsel from pursuing the case aggressively (perhaps settling the case at a substantial discount), or from accepting the case in the first place. The upshot may be to make it more difficult for persons injured by medical malpractice to sue.
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Over the ten year period studied, medical malpractice trials in Virginia and North Carolina were similar in many ways. Appeals were few, and rarely changed the result at trial. While about half the cases in both states began with multiple defendants, by the time of trial most cases involved only a single defendant. The cases that went to trial usually involved serious injuries. In both states, plaintiffs alleged permanent injuries (rather than temporary, or emotional) in more than 70% of the trials. The same three specialties were taken to trial most often in both states: general surgery, Ob-Gyn, and orthopedic surgery. The most frequent non-surgical specialty taken to trial in both states was internal medicine. Attending physicians were taken to trial more often than consulting physicians. A hospital was the most likely location where the alleged malpractice took place, followed by the practitioner's office.
In both states, plaintiff's allegations most often involved either the musculoskeletal system or the digestive system, followed by the cardiovascular system and the reproductive system. The allegations were most often surgery, diagnosis, or treatment related. In both states, the plaintiff fared best when the allegations were diagnosis related, and worst when the allegations were surgery related. The most common medical allegations were inappropriate or incomplete treatment; failure to diagnose disease; and failure to monitor the patient's status while in treatment. Most of the cases that went to trial were assessed by the insurer as cases of either no or doubtful liability.
In both states, a relatively large number of plaintiffs' attorneys faced a much more concentrated group of defense counsel. In both states, very few plaintiffs' attorneys who had tried three or more cases had winning records; in contrast, almost all of the defense counsel in Virginia and North Carolina had winning records.
Plaintiffs in both states ranged in age from infancy to old age. More than half were female, and more than half were married. Most plaintiffs were white, but in both states, African-American plaintiffs had a better chance of success at trial. In Virginia, women had a slightly better chance of success at trial than men. In both states, about half of the plaintiffs were employed (either full-time, part-time, or self-employed). Most plaintiffs had private medical insurance. The success rate at trial for Medicare plaintiffs was less than the success rate for plaintiffs with private insurance.
In spite of the many similarities, however, there were some noticeable differences. Trials took longer in North Carolina -a median of 8 days, compared to a median of 3.5 days in Virginia. Trials were more expensive in North Carolina. Plaintiffs' verdicts, when obtained, tended to be higher in Virginia. Finally, plaintiffs fared much better at trial in Virginia than they did in North Carolina.
Why the difference in outcomes? A clear reason does not emerge from the data. The law of torts is largely the same in both states. Perhaps Virginia juries are more generous to plaintiffs than North Carolina juries are, or perhaps defense counsel in North Carolina are more aggressive than their counterparts in Virginia. Or it may be that small distinctions lead to large differences. For example, medical malpractice trials in North Carolina ran, on average, twice as long as medical malpractice trials in Virginia. This difference may explain the higher expenses for trials in North Carolina. It may also be that longer personal injury trials favor defendants; perhaps time is needed for the jury, confronted with evidence of a seriously injured plaintiff, to accept the idea that the plaintiff's injury does not necessarily mean that the defendant is responsible for that injury. In addition, seven person civil juries in Virginia are the rule 52 ; in North Carolina, civil juries consist of twelve persons.
53 Perhaps a larger number of jurors helps explain the disparity in outcomes between the two states. It might be that Virginia's limitation on the number of experts who may be called to testify 54 works to the disadvantage of physician defendants. In most medical malpractice cases, it is easier for the defense to obtain willing experts, than it is for the plaintiff. Limiting the number of experts at trial restricts the ability of the defense to present what might appear to the jury as a majority or consensus view -if the jury simply counts the number of experts. In any event, further research seems called for.
There is one other explanation, although it, too, is speculation. The most obvious difference between Virginia and North Carolina practice is the existence of a "hard cap" on damages in Virginia. The cap has been in place in Virginia for over thirty years. 55 It is plaintiffs' counsel -the gatekeepers-who are most aware of the cap and its effect. Perhaps the cap affects the types of cases plaintiffs' counsel decide to take. With a "hard cap" in place, a case with a potentially multimillion dollar award but encumbered with one or more "problems" -questionable liability, perhaps, or an unattractive plaintiff -becomes less attractive. Without the potentially high payoff to balance the risk of questionable liability, why take the case? Instead, the more logical approach would be to put more emphasis on cases that plaintiffs' counsel believes can be won. If this strategy is followed, and if plaintiffs' counsel is adept at picking her cases, a higher "win" rate at trial should follow. Perhaps the "hard cap" on damages discourages taking high risk/high reward cases, but does not discourage taking cases where the odds of prevailing seem favorable. North Carolina's newly enacted "soft cap" should provide additional evidence on this question. Perhaps the "soft cap" will lead to more careful case selection by plaintiffs' counsel. However, due to the limit on non-economic damages, the cap may also make it more difficult for plaintiffs with limited economic damages to retain qualified counsel.
V. Conclusion
The more things changed, the more they stayed the same. Going to trial as a plaintiff in a medical malpractice action was a long shot twenty years ago, and it remains so today. The number of medical malpractice cases filed has declined in 54 See note 18, supra. 55 See notes 7-13, supra and the accompanying text. recent years. 56 Why is this so? There are a number of plausible explanations, but two reasons are suggested by our data. First is the "repeat player" effect, as seen at the attorney level. The defense lawyers in our data, on average, tried numerous cases. The same is not true of plaintiff's counsel. With experience comes expertise -especially if the insurer is monitoring results. Or perhaps plaintiff's lawyers with a large medical liability practice know better than to take a case to trial. The second reason is more basic. The results we report reflect selection bias. The insurer, in consultation with its attorneys, seeks to settle cases it believes will be difficult to win. It is very difficult for most plaintiffs, and their counsel, to reject a settlement offer, particularly in light of the lop-sided outcomes at trial. The result is a pattern of results that strongly favor the defense. That pattern alone provides the insurer with substantial bargaining power in the context of settlement negotiations -an event that happens much more frequently than trials do.
